LeafNLP Demos
Back to explore

Report #2875096

Received Nov 26, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
CT
Recovered
Unknown
Vaccinated
Oct 24, 2025
Onset
Oct 24, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNKZ010457OT

Symptoms (2)

Incorrect route of product administrationNo adverse event

Symptom narrative

no adverse event; Pharmacist calling to report that his pharmacy administered a CAPVAXIVE via subcutaneously instead of intramuscularly. No side effects reported. No other AE/No PQC.; This spontaneous report was received from a pharmacist and refers to a 64-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 24-OCT-2025, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine Solution for injection (CAPVAXIVE) (lot #Z010457 was valid, expiration date: 26-NOV-2026, 0.5 mL once, administered by Subcutaneous route) for prophylaxis (Intramuscular formulation administered by other route). No side effects reported (No adverse event). No product quality complaint (PQC).